title: Cell-kinetic alterations induced by aspirin in human gastric mucosa and their prevention by a cytoprotective agent.
abstract: The effect on gastric epithelial cell proliferation of a short-term, low-dose treatment with aspirin was evaluated in 9 healthy volunteers. Nine days before and during aspirin administration, the subjects assumed sulglycotide, a sulfated glycopeptide with cytoprotective properties. Endoscopic biopsies were collected in each subject from the gastric body and antrum before and after treatment. The specimens were incubated in a culture medium containing bromodeoxyuridine (BrdU). The proliferative activity was evaluated by immunohistochemical detection of BrdU uptake. A decrease in BrdU-labelled cells together with a shortening of the length of gastric columns were observed after treatment with aspirin and placebo in biopsies of both body and antrum (p less than 0.05). On the contrary, no modifications were observed after treatment with aspirin and sulglycotide. We conclude that a decrease in the proliferative activity of the epithelial cells could be one of the mechanisms by which aspirin affects the defensive properties of gastric mucosa. The treatment with a cytoprotective drug seems to be effective in preventing this alteration.
authors.affiliation: Istituto di Clinica Medica e Gastroenterologia, Università di Bologna, Italia.
authors.forename: G
authors.initials: G
authors.lastname: Biasco
authors.forename: G M
authors.initials: GM
authors.lastname: Paganelli
authors.forename: G
authors.initials: G
authors.lastname: Di Febo
authors.forename: S
authors.initials: S
authors.lastname: Siringo
authors.forename: L
authors.initials: L
authors.lastname: Barbara
mesh_terms: D000328:Adult; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001241:Aspirin / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002455:Cell Division; D003470:Culture Media; D004311:Double-Blind Method; D004847:Epithelial Cells; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D011706:Pyloric Antrum / Q000166:cytology / Q000187:drug effects; D012795:Sialoglycoproteins / Q000494:pharmacology*
chemical_list: D000897:Anti-Ulcer Agents; D003470:Culture Media; D012795:Sialoglycoproteins; C009354:sulglicotide; D001973:Bromodeoxyuridine; D001241:Aspirin